
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice
- Author
- Flor Verghote (UGent) , Charles Van Praet (UGent) , Camille Berquin (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Ben Vanneste (UGent) , Elke Rammant (UGent) and Valerie Fonteyne (UGent)
- Organization
- Project
- Abstract
- BackgroundThis study aims to explore the priorities and counselling needs of patients with muscle-invasive bladder cancer faced with a decision between radical cystectomy and trimodality therapy.MethodsWe performed a qualitative study according to the phenomenological approach. Sixteen muscle-invasive bladder cancer survivors who underwent radical cystectomy or trimodality therapy completed a semi-structured interview between May 2022 and February 2023. Patients were recruited via Ghent University Hospital and a patient organisation. Data were analysed with inductive thematic analysis by a multi-disciplinary team using an iterative approach and investigators' triangulation.ResultsFour main priorities determining the treatment decision were identified. (1) curing the disease; (2) health-related quality of life (physical, mental and social); (3) confidence in the treatment, which was mainly based on trust in the clinician; and (4) personal attributes. Trust in the clinician can be achieved by fulfilling the patient's information needs (accurate, complete, clear, impartial, personalised, realistic, and transparent information), ensuring accessibility of the clinician, and creating a clear and personalised treatment plan, involving patients to the extend they desire. Many patients considered a patient decision aid as a valuable asset in this process.ConclusionPriorities vary between patients with muscle-invasive bladder cancer. Identifying individual priorities and offering personalised information about them is crucial for ensuring trust in the clinician and confidence in the treatment. Use of a patient decision aid can be beneficial in this process.
- Keywords
- Cancer Research, Genetics, Oncology, Patient preference, Patient decision aid, Muscle-invasive bladder cancer, Cystectomy
Downloads
-
s12885-024-11927-1 (1).pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.20 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HNMM9EP7XTA9VFMN4CP2FB0H
- MLA
- Verghote, Flor, et al. “Radical Cystectomy or Trimodality Therapy for Muscle-Invasive Bladder Cancer : A Qualitative Study Exploring Patient Priorities and Counselling Needs When Making a Treatment Choice.” BMC CANCER, vol. 24, no. 1, Springer Science and Business Media LLC, 2024, doi:10.1186/s12885-024-11927-1.
- APA
- Verghote, F., Van Praet, C., Berquin, C., Lumen, N., Decaestecker, K., Vanneste, B., … Fonteyne, V. (2024). Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice. BMC CANCER, 24(1). https://doi.org/10.1186/s12885-024-11927-1
- Chicago author-date
- Verghote, Flor, Charles Van Praet, Camille Berquin, Nicolaas Lumen, Karel Decaestecker, Ben Vanneste, Elke Rammant, and Valerie Fonteyne. 2024. “Radical Cystectomy or Trimodality Therapy for Muscle-Invasive Bladder Cancer : A Qualitative Study Exploring Patient Priorities and Counselling Needs When Making a Treatment Choice.” BMC CANCER 24 (1). https://doi.org/10.1186/s12885-024-11927-1.
- Chicago author-date (all authors)
- Verghote, Flor, Charles Van Praet, Camille Berquin, Nicolaas Lumen, Karel Decaestecker, Ben Vanneste, Elke Rammant, and Valerie Fonteyne. 2024. “Radical Cystectomy or Trimodality Therapy for Muscle-Invasive Bladder Cancer : A Qualitative Study Exploring Patient Priorities and Counselling Needs When Making a Treatment Choice.” BMC CANCER 24 (1). doi:10.1186/s12885-024-11927-1.
- Vancouver
- 1.Verghote F, Van Praet C, Berquin C, Lumen N, Decaestecker K, Vanneste B, et al. Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice. BMC CANCER. 2024;24(1).
- IEEE
- [1]F. Verghote et al., “Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice,” BMC CANCER, vol. 24, no. 1, 2024.
@article{01HNMM9EP7XTA9VFMN4CP2FB0H, abstract = {{BackgroundThis study aims to explore the priorities and counselling needs of patients with muscle-invasive bladder cancer faced with a decision between radical cystectomy and trimodality therapy.MethodsWe performed a qualitative study according to the phenomenological approach. Sixteen muscle-invasive bladder cancer survivors who underwent radical cystectomy or trimodality therapy completed a semi-structured interview between May 2022 and February 2023. Patients were recruited via Ghent University Hospital and a patient organisation. Data were analysed with inductive thematic analysis by a multi-disciplinary team using an iterative approach and investigators' triangulation.ResultsFour main priorities determining the treatment decision were identified. (1) curing the disease; (2) health-related quality of life (physical, mental and social); (3) confidence in the treatment, which was mainly based on trust in the clinician; and (4) personal attributes. Trust in the clinician can be achieved by fulfilling the patient's information needs (accurate, complete, clear, impartial, personalised, realistic, and transparent information), ensuring accessibility of the clinician, and creating a clear and personalised treatment plan, involving patients to the extend they desire. Many patients considered a patient decision aid as a valuable asset in this process.ConclusionPriorities vary between patients with muscle-invasive bladder cancer. Identifying individual priorities and offering personalised information about them is crucial for ensuring trust in the clinician and confidence in the treatment. Use of a patient decision aid can be beneficial in this process.}}, articleno = {{160}}, author = {{Verghote, Flor and Van Praet, Charles and Berquin, Camille and Lumen, Nicolaas and Decaestecker, Karel and Vanneste, Ben and Rammant, Elke and Fonteyne, Valerie}}, issn = {{1471-2407}}, journal = {{BMC CANCER}}, keywords = {{Cancer Research,Genetics,Oncology,Patient preference,Patient decision aid,Muscle-invasive bladder cancer,Cystectomy}}, language = {{eng}}, number = {{1}}, pages = {{10}}, publisher = {{Springer Science and Business Media LLC}}, title = {{Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice}}, url = {{http://doi.org/10.1186/s12885-024-11927-1}}, volume = {{24}}, year = {{2024}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: